Reduced cerebrospinal fluid mitochondrial DNA is a biomarker for early‐stage Parkinson's disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1531-8249|78|6|1000-1004

ISSN： 0364-5134

Source： ANNALS OF NEUROLOGY, Vol.78, Iss.6, 2015-12, pp. : 1000-1004

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Somatostatin‐Like Immunoreactivity in the Cerebrospinal Fluid of Aged Patients with Parkinson's Disease

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 38, Iss. 1, 1990-01 ,pp. : 19-24

John Wiley & Sons Inc

Access to resources Recommend Favorite

ELEVATED CEREBROSPINAL FLUID TAU LEVELS: IMPLICATIONS FOR THE EARLY DIAGNOSIS OF ALZHEIMER'S DISEASE

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 44, Iss. 8, 1996-08 ,pp. : 1012-1013

John Wiley & Sons Inc

Access to resources Recommend Favorite

Platelet mitochondrial activity and pesticide exposure in early Parkinson's disease

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 6, 2015-05 ,pp. : 862-866

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cerebrospinal fluid Aβ42 levels and APP processing pathway genes in Parkinson's disease

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 7, 2015-06 ,pp. : 936-944

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features

By  

MOVEMENT DISORDERS, Vol. 33, Iss. 2, 2018-02 ,pp. : 282-288

John Wiley & Sons Inc

Access to resources Recommend Favorite